(0.12%) 5 137.75 points
(0.08%) 38 472 points
(0.18%) 17 877 points
(-0.31%) $83.59
(1.56%) $1.953
(0.29%) $2 354.10
(0.56%) $27.69
(1.45%) $935.50
(-0.16%) $0.933
(-0.34%) $10.99
(-0.28%) $0.798
(1.24%) $93.01
Live Chart Being Loaded With Signals
UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally...
Stats | |
---|---|
本日の出来高 | 3.14M |
平均出来高 | 2.82M |
時価総額 | 0.00 |
EPS | £0.0573 ( 2019-06-29 ) |
Last Dividend | £0.125 ( 2021-01-07 ) |
Next Dividend | £0 ( N/A ) |
P/E | 0.420 |
ATR14 | £0 (0.00%) |
UDG Healthcare plc 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
UDG Healthcare plc 財務諸表
Annual | 2020 |
収益: | £1.28B |
総利益: | £394.83M (30.87 %) |
EPS: | £0.373 |
FY | 2020 |
収益: | £1.28B |
総利益: | £394.83M (30.87 %) |
EPS: | £0.373 |
FY | 2019 |
収益: | £1.30B |
総利益: | £371.14M (28.58 %) |
EPS: | £0.231 |
FY | 2018 |
収益: | £1.32B |
総利益: | £381.60M (29.02 %) |
EPS: | £0.0153 |
Financial Reports:
No articles found.
UDG Healthcare plc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
First Dividend | £0.00468 | 1990-01-29 |
Last Dividend | £0.125 | 2021-01-07 |
Next Dividend | £0 | N/A |
Payout Date | 2021-02-05 | |
Next Payout Date | N/A | |
# dividends | 63 | -- |
Total Paid Out | £1.931 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 4.03 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.26 | |
Div. Directional Score | 8.01 | -- |
Year | Amount | Yield |
---|---|---|
1990 | £0 | 0.00% |
1991 | £0 | 0.00% |
1992 | £0 | 0.00% |
1993 | £0 | 0.00% |
1994 | £0 | 0.00% |
1995 | £0 | 0.00% |
1996 | £0 | 0.00% |
1997 | £0 | 0.00% |
1998 | £0 | 0.00% |
1999 | £0 | 0.00% |
2000 | £0 | 0.00% |
2001 | £0 | 0.00% |
2002 | £0 | 0.00% |
2003 | £0 | 0.00% |
2004 | £0 | 0.00% |
2005 | £0 | 0.00% |
2006 | £0 | 0.00% |
2007 | £0 | 0.00% |
2008 | £0 | 0.00% |
2009 | £0 | 0.00% |
2010 | £0 | 0.00% |
2011 | £0 | 0.00% |
2012 | £0 | 0.00% |
2013 | £0 | 0.00% |
2014 | £0 | 0.00% |
2015 | £0 | 0.00% |
2016 | £0 | 0.00% |
2017 | £0 | 0.00% |
2018 | £0 | 0.00% |
2019 | £0 | 0.00% |
2020 | £0.168 | 0.02% |
2021 | £0.125 | 0.02% |
2022 | £0 | 0.00% |
2023 | £0 | 0.00% |
2024 | £0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SHG.L | Dividend Knight | 2023-11-02 | Semi-Annually | 4 | 0.91% | |
IHP.L | Dividend Knight | 2023-06-08 | Semi-Annually | 7 | 1.08% | |
BOCH.L | Dividend Junior | 2023-05-04 | Insufficient data to determine frequency | 2 | 1.10% | |
OCN.L | Dividend Knight | 2023-05-18 | Annually | 19 | 3.96% | |
ESNT.L | Dividend King | 2023-09-21 | Semi-Annually | 20 | 4.44% | |
STAN.L | Dividend Junior | 2023-08-10 | Annually | 32 | 1.92% | |
JMAT.L | Dividend Knight | 2023-06-08 | Semi-Annually | 33 | 1.93% | |
CAPD.L | Dividend King | 2023-08-31 | Semi-Annually | 10 | 2.58% | |
PSHD.L | No Dividend Player | 2023-08-17 | Annually | 6 | 0.41% | |
GCP.L | Dividend King | 2023-08-10 | Quarterly | 15 | 3.86% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0726 | 1.500 | 8.55 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0526 | 1.200 | 8.25 | 9.90 | [0 - 0.3] |
returnOnEquityTTM | 0.0986 | 1.500 | -0.0160 | -0.0240 | [0.1 - 1] |
payoutRatioTTM | 0.453 | -1.000 | 5.47 | -5.47 | [0 - 1] |
currentRatioTTM | 1.919 | 0.800 | 5.41 | 4.32 | [1 - 3] |
quickRatioTTM | 0.791 | 0.800 | -0.0553 | -0.0442 | [0.8 - 2.5] |
cashRatioTTM | 0.791 | 1.500 | 6.72 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.167 | -1.500 | 7.22 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 8.87 | 1.000 | 7.83 | 7.83 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.926 | 2.00 | 9.69 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.774 | 2.00 | 9.61 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.299 | -1.500 | 8.81 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.309 | 1.000 | 8.19 | 8.19 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0995 | 1.000 | -0.0102 | -0.0102 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.785 | 1.000 | 6.75 | 6.75 | [0.2 - 2] |
assetTurnoverTTM | 0.725 | 0.800 | 8.50 | 6.80 | [0.5 - 2] |
Total Score | 10.75 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 36.30 | 1.000 | 6.43 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0986 | 2.50 | -0.0103 | -0.0240 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.774 | 2.00 | 9.74 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.926 | 2.00 | 9.69 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.453 | 1.500 | 5.47 | -5.47 | [0 - 1] |
pegRatioTTM | 47.57 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.180 | 1.000 | 7.99 | 0 | [0.1 - 0.5] |
Total Score | 5.26 |
UDG Healthcare plc
UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services. This segment supports healthcare professionals and patients at various stages of the product life cycle; and provides field and contact center sales teams, healthcare communications, patient support, audit, advisory, medical information, and event management services to approximately 300 healthcare companies. The Sharp segment provides contract and clinical trial packaging services for the pharmaceutical and biotechnology industries; serialization solutions; and clinical IRT services. The company was formerly known as United Drug plc and changed its name to UDG Healthcare plc in August 2013. UDG Healthcare plc was founded in 1948 and is based in Dublin, the Republic of Ireland.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。